Stacy Price
Chief Technology OfficerMs. Stacy Price, M.S. PMP, served as Chief Technology & Manufacturing Officer of Invivyd, Inc. since March 2023 until December 2024. She serves as Chief Technology Officer at Upstream Bio, Inc. since June 2025. She served as Chief Technical Officer of Akouos, Inc. from November 2021 until February 2023. Ms. Price brings to Akouos experience in managing clinical and commercial biotechnology manufacturing and technical operations for a wide range of therapeutic modalities, including gene therapy. Ms. Price was most recently senior vice president of technical operations at Ziopharm Oncology, where she was accountable for development and delivery of CMC strategy for cell and combination gene therapy products and for establishing the company’s clinical manufacturing capability. Prior to Ziopharm, Ms. Price was head of pharmaceutical development operations at Shire, where she led CMC program management as well as laboratory and pilot plant operations and set overall operations strategy. She holds a Master of Science and B.S. in Biochemical Engineering from Tufts University.
Positions
- Company NameUpstream Bio, Inc.Stock CodeUPBPositionChief Technology OfficerColleagues
- ERE. Rand SutherlandCEO & Director
- RCRonald C. RenaudIndependent Chairman of the Board
- MPMichael Paul GrayCFO & COO
- ADAaron DeykinChief Medical Officer and Head of Research & Development
- MBMeggan BuckwellDirector of Corporate Communications & Investor Relations
- MKMarcella Kuhlman RuddyIndependent Director
- DBDaniella BeckmanIndependent Director
- ECErez ChimovitsIndependent Director
